A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response

James M. Foran, Rajnish K. Gupta, David Cunningham, Razvan A. Popescu, Anthony H. Goldstonk, John W. Sweetenham, Ruth Pettengell, Peter W.M. Johnson, Eric Bessell, Barry Hancock, Karin Summers, Julia Hughes, Ama Z.S. Rohatiner, T. Andrew Lister

Research output: Contribution to journal › Article › peer-review